ArticleExperimental and molecular pathology2026

Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancer.

Toru Sakatani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.